rss
Br J Ophthalmol 2007;91:1096
  • Mailbox

Isotretinoin and night vision

  1. S Pushpoth,
  2. S Sandramouli
  1. Wolverhampton and Midland Counties Eye Infirmary, Wolverhampton, UK
  1. Correspondence to: Dr S Pushpoth Wolverhampton and Midland Counties Eye Infirmary, Compton Road, Wolverhampton WV3 9QR, UK; drsree{at}tiscali.co.uk
  • Accepted 24 October 2006

We read with interest the article by Mollan et al1 who have concluded that previous isotretinoin use does not cause a clinically significant reduction in night vision in most people, and that the retinal toxic effects of isotretinoin may be measurable by electroretinography (ERG) and dark adaptation (DA). Although the authors have successfully highlighted the importance of counselling patients for potential irreversible loss of DA following isotretinoin use, their report, in our opinion, has failed to substantiate the need for routine screening of potential military and civilian commercial aviators.

In their study, 2 of 47 patients …

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.